ORY-4001

N/A

Report date: 2023/06/15 16:52:31
NME

Base Information

Drug NameORY-4001
Drug Alias NameORY-4001
ClassificationSmall molecules
Mechanisms of ActionHistone deacetylase 6 inhibitors
TargetsHistone deacetylase 6
Therapy Area/IndicationsCharcot-Marie-Tooth DiseaseAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOryzon Genomics Sa
China Registration ClassN/A

Develop Information

Active CompaniesOryzon Genomics Sa
Inactive CompaniesN/A
Active IndicationsCharcot-Marie-Tooth DiseaseAmyotrophic Lateral Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A